España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Valeant Pharmaceuticals
Barron's Picks And Pans: Arista, Kroger, SeaWorld, Valeant And More
Benzinga's Bulls & Bears Of The Week: Amazon, Costco, Netflix, Tesla And More
Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo
Benzinga's Bulls & Bears Of The Week: Amazon, Costco, Netflix, Tesla And More
Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo
What Did Valeant Look Like Last Time The Stock Was Under $15?
A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer
What Did Valeant Look Like Last Time The Stock Was Under $15?
A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer
Generic Drugs In The Earnings Spotlight: Mylan And Valeant Pharmaceuticals
Barron's Picks And Pans: Intercontinental Exchange, Visteon And More
Read More...
Valeant Pharmaceuticals Recent News
Valeant Spikes 6%, WSJ Says Company Close To Hiring Perrigo's Chief As New CEO
Report: Valeant More Likely To Sell Drugs Than Business Units
Valeant Shares Squeezed Higher As Ad Hoc Committee Closes Review, Finds No Added Issues
Valeant In Breach Of Canadian Regulations
Barron's Picks And Pans: FedEx, Ilumina And More
Canadian Authorities Could Be Looking Into Valeant
Hillary Clinton: 'I'm Going After' Valeant
UPDATE: Valeant Plunges 7% After Bearish Wells Fargo Report
Why Shares Of Valeant Pharmaceuticals Spiked
Investment Firm That Held Stake In Valeant Sued By Investors
Valeant Names Howard Schiller As Interim CEO As Mike Pearson Remains In The Hospital
Valeant Confirms CEO Will Be On Medical Leave Of Absence
Valeant's Stock Drops, Then Recovers, Following False Report Of FBI Raid
Barron's Recap: How To Live Well
Barron's Recap: Barnes & Noble, DSW Could Skyrocket
General Motors, Annaly Capital And Others Insiders Have Been Buying
Barron's Recap: Why Honeywell Is Better Than GE
Markets End Week On Positive Note As Investors Are Encouraged By Central Bank Developments In Europe, China
#PreMarket Primer: Friday, November 21: Immigration Reform Could Have Lasting Impact In More Ways Than One
Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble
Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook
Cramer's Watchlist: Target And Lowe's Rebound As Hertz Remains In The Red
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs